Comparing Xengenic Cortical Membranes and Connective Tissue Grafts with Coronally Advanced Flap for Treating Peri-implant Soft Tissue Dehiscences in Adults Aged 20 to 50

What this Trial Is About

Peri-implant soft tissue dehiscences are common problems in implant dentistry that cause challenges for both appearance and function. Researchers are comparing two treatments Xengenic cortical membranes and connective tissue graft with coronally advanced flap, to find which is better for improving soft tissue around implants. This is a randomized, controlled clinical trial aimed at evaluating outcomes and patient experiences with these treatments. The trial involves two groups receiving different soft tissue surgeries around dental implant dehiscence. One group is treated with Xengenic cortical membranes, a device used to support tissue regeneration. The other group receives a connective tissue graft combined with a coronally advanced flap procedure. Both treatments are provided under controlled conditions as part of the study. Participants will be monitored over six months to assess changes in peri-implant soft tissue thickness, which is the main outcome measure. Researchers will also evaluate the pink esthetic score to understand the appearance improvements. Throughout the study, participants compliance and oral hygiene will be tracked to support treatment success. The study duration includes regular visits and assessments for accurate measurement of the results.

Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial